Log in to save to my catalogue

Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential

Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10229853

Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential

About this item

Full title

Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential

Publisher

US: Oxford University Press

Journal title

The international journal of neuropsychopharmacology, 2023-05, Vol.26 (5), p.309-321

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Redox biology and immune signaling play major roles in the body, including in brain function. A rapidly growing literature also suggests that redox and immune abnormalities are implicated in neuropsychiatric conditions such as schizophrenia (SZ), bipolar disorder, autism, and epilepsy. In this article we review this literature, its impl...

Alternative Titles

Full title

Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10229853

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10229853

Other Identifiers

ISSN

1461-1457,1469-5111

E-ISSN

1469-5111

DOI

10.1093/ijnp/pyad012

How to access this item